It results in fusion of the promoter of the collagen type Iα1 gene (COL1A1) and the platelet-derived growth factor B-chain (PDGFB) genes, which ultimately contribute to continuous autocrine production of local PDGF, promoting tumour growth [6,7]. The gene discussed is PDGFB; the disease is neoplasm.